Medical Properties Trust, Inc.
MPTNYSECIK 1287865Real Estate / REITsfiscal year ends December67 quarters since 2010
Latest quarter Q3 FY2026, filed November 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.
Share price
Daily candlesticks from November 18, 2024 to November 13, 2026, with each earnings release marked; a release after the close marks the day it came out, so its reaction is the next candle. See this earnings season for every company’s reaction.
The last 16 quarters
Q4 FY2022 to Q3 FY2026, through the filing of November 6, 2026.
Net income losses drawn in red.
Positions at each quarter end, as filed; short-term investments are not included.
Income statement
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 9, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 250 | 259 | 252 | 270 | 238 | 240 | 224 | 232 | +5.3% |
| Cost of revenue | (33) | 12 | 97 | 11 | (22) | 20 | 81 | 21 | −46.2% |
| Gross profit | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 29 | 35 | 32 | 25 | 38 | 26 | 42 | 28 | −23.1% |
| Operating income | — | — | — | — | — | — | — | — | — |
| Other income (expense) | 226 | (1) | (7) | (11) | (58) | (95) | (103) | (430) | +489.5% |
| Pretax income | 212 | 8 | 0 | 26 | (67) | (88) | (109) | (403) | +418.6% |
| Income tax | 10 | 10 | (33) | 9 | 11 | 10 | 9 | 10 | −7.8% |
| Net income | 202 | (3) | 33 | 17 | (78) | (98) | (118) | (413) | +359.3% |
| Diluted EPS ($) | 0.34 | (0.01) | 0.05 | — | (0.13) | (0.16) | (0.20) | — | +361.5% |
| Diluted shares (millions) | 597 | 598 | 598 | — | 601 | 601 | 601 | — | — |
Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.
Balance sheet
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 9, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 599 | 397 | 425 | 541 | 397 | 510 | 673 | 332 | +51.1% |
| Short-term investments | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — |
| Total assets | 14,394 | 14,748 | 14,763 | 15,002 | 14,924 | 15,150 | 14,854 | 14,295 | −3.6% |
| Total current liabilities | — | — | — | — | — | — | — | — | — |
| Long-term debt | 9,260 | 9,705 | 9,663 | 9,698 | 9,616 | 9,649 | 9,465 | 8,848 | −3.7% |
| Total debt | 9,260 | 9,705 | 9,663 | 9,698 | 9,616 | 9,649 | 9,465 | 8,848 | −3.7% |
| Total liabilities | 9,771 | 10,248 | 10,217 | 10,395 | 10,263 | 10,317 | 10,092 | 9,461 | −4.8% |
| Stockholders’ equity | 4,621 | 4,499 | 4,545 | 4,606 | 4,660 | 4,833 | 4,761 | 4,833 | −0.8% |
| Shares outstanding (millions) | 589 | 597 | 598 | 598 | 602 | 601 | 601 | 601 | — |
Positions at each period end. Long-term debt is the line the filer tags, with or without its current portion. Total debt is one definition across filers, built from filed lines: long-term debt with its current portion plus short-term borrowings, finance leases where the filer folds them into its debt line, operating leases never; it is blank where the tags do not add up to it. Italic figures are derived.
Cash flow statement
Last eight quarters, newest first, through Q3 FY2026 filed November 6, 2026.
| Millions of dollars | Q3 FY2026ended Sep 30, 2026filed Nov 6, 2026 | Q2 FY2026ended Jun 30, 2026filed Aug 10, 2026 | Q1 FY2026ended Mar 31, 2026filed May 8, 2026 | Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026 | Q3 FY2025ended Sep 30, 2025filed Nov 7, 2025 | Q2 FY2025ended Jun 30, 2025filed Aug 8, 2025 | Q1 FY2025ended Mar 31, 2025filed May 9, 2025 | Q4 FY2024ended Dec 31, 2024filed Mar 3, 2025 | YoYQ3 FY2026vs Q3 FY2025 |
|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 41 | 62 | (14) | 160 | 19 | 52 | 0 | 77 | +121.5% |
| Capital expenditures | — | — | — | — | — | — | — | — | — |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | — | — | — |
| Depreciation and amortization | 70 | 69 | 73 | withheld | withheld | withheld | withheld | 66 | — |
| Share repurchases | 0 | — | — | 23 | 0 | — | — | — | — |
| Dividends paid | 54 | 54 | 55 | 48 | 48 | 48 | 48 | 48 | +12.2% |
10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.
Annual statements
Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.
Income statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Feb 27, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 29, 2016 | FY2014ended Dec 31, 2014filed Mar 2, 2015 | FY2013ended Dec 31, 2013filed Mar 3, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed May 10, 2011 | FY2009ended Dec 31, 2009filed May 10, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 972 | 996 | 872 | 1,543 | 1,545 | 1,249 | 854 | 785 | 705 | 541 | 442 | 313 | 243 | 198 | 132 | 108 | 114 |
| Cost of revenue | 90 | 74 | 110 | 167 | 101 | 30 | 168 | 84 | — | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Research and development | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Selling, general and administrative | 130 | 134 | 146 | 160 | 146 | 132 | 96 | 81 | 59 | 49 | 44 | 37 | 30 | 29 | 27 | 27 | 21 |
| Operating income | — | — | — | — | — | — | — | — | 486 | 342 | 263 | 143 | 154 | 130 | 70 | 42 | 68 |
| Other income (expense) | (267) | (2,333) | (357) | 315 | 60 | (36) | 30 | 681 | (15) | 30 | (123) | (92) | (64) | (57) | (58) | (39) | (38) |
| Pretax income | (237) | (2,364) | (687) | 960 | 731 | 463 | 374 | 1,019 | 294 | 219 | 141 | 51 | 90 | 73 | — | — | — |
| Income tax | 39 | 44 | (131) | 56 | 74 | 31 | (3) | 1 | 3 | (7) | 2 | 0 | 1 | 0 | 0 | 2 | 0 |
| Net income | (277) | (2,410) | (556) | 903 | 656 | 431 | 375 | 1,017 | 290 | 225 | 140 | 51 | 97 | 90 | 27 | 23 | 36 |
| Diluted EPS ($) | (0.46) | (4.02) | (0.93) | 1.50 | 1.11 | 0.81 | 0.87 | 2.76 | 0.82 | 0.86 | 0.63 | 0.29 | 0.63 | 0.67 | 0.23 | 0.22 | 0.45 |
| Diluted shares (millions) | 601 | 600 | 599 | 599 | 590 | 530 | 428 | 366 | 350 | 261 | 218 | 171 | 153 | 132 | 111 | 101 | 78 |
Balance sheet
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Feb 27, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 29, 2016 | FY2014ended Dec 31, 2014filed Mar 2, 2015 | FY2013ended Dec 31, 2013filed Mar 3, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed May 10, 2011 | FY2009ended Dec 31, 2009filed May 10, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 541 | 332 | 250 | 236 | 459 | 550 | 1,462 | 821 | 171 | 83 | 196 | 145 | 46 | 37 | 103 | 98 | 15 |
| Short-term investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total current assets | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | 15,002 | 14,295 | 18,305 | 19,658 | 20,520 | 16,829 | 14,467 | 8,844 | 9,020 | 6,419 | 5,609 | 3,720 | 2,905 | 2,179 | 1,622 | 1,349 | — |
| Total current liabilities | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Long-term debt | 9,698 | 8,848 | 10,064 | 10,268 | 11,283 | 8,865 | 7,024 | 4,037 | 4,899 | 2,909 | 3,349 | 2,199 | 1,422 | 1,025 | 690 | 370 | — |
| Total debt | 9,698 | 8,848 | 10,064 | 10,268 | 11,283 | 8,865 | 7,024 | 4,037 | 4,899 | 2,909 | 3,349 | 2,199 | 1,422 | 1,025 | 690 | 370 | — |
| Total liabilities | 10,395 | 9,461 | 10,671 | 11,064 | 12,074 | 9,485 | 7,439 | 4,283 | 5,185 | 3,165 | 3,502 | 2,338 | 1,560 | 1,129 | 793 | 449 | — |
| Stockholders’ equity | 4,606 | 4,833 | 7,632 | 8,593 | 8,440 | 7,339 | 7,028 | 4,547 | 3,821 | 3,248 | 2,102 | 1,382 | 1,344 | 1,050 | 829 | 899 | — |
| Shares outstanding (millions) | 598 | 601 | 599 | 598 | 600 | 580 | 521 | 381 | 365 | 321 | 238 | 209 | 163 | 137 | 135 | — | — |
Cash flow statement
| Millions of dollars | FY2025ended Dec 31, 2025filed Feb 26, 2026 | FY2024ended Dec 31, 2024filed Mar 3, 2025 | FY2023ended Dec 31, 2023filed Feb 29, 2024 | FY2022ended Dec 31, 2022filed Mar 1, 2023 | FY2021ended Dec 31, 2021filed Mar 1, 2022 | FY2020ended Dec 31, 2020filed Mar 1, 2021 | FY2019ended Dec 31, 2019filed Feb 27, 2020 | FY2018ended Dec 31, 2018filed Mar 1, 2019 | FY2017ended Dec 31, 2017filed Mar 1, 2018 | FY2016ended Dec 31, 2016filed Mar 1, 2017 | FY2015ended Dec 31, 2015filed Feb 29, 2016 | FY2014ended Dec 31, 2014filed Mar 2, 2015 | FY2013ended Dec 31, 2013filed Mar 3, 2014 | FY2012ended Dec 31, 2012filed Feb 22, 2013 | FY2011ended Dec 31, 2011filed Feb 29, 2012 | FY2010ended Dec 31, 2010filed May 10, 2011 | FY2009ended Dec 31, 2009filed May 10, 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 231 | 245 | 506 | 739 | 812 | 618 | 494 | 449 | 362 | 264 | 207 | 150 | 141 | 105 | 79 | 61 | 63 |
| Capital expenditures | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Free cash flow (CFO − capex) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation and amortization | 273 | 454 | 616 | 346 | 334 | 276 | 157 | 141 | 132 | 98 | 72 | 55 | 39 | 36 | 35 | 26 | 26 |
| Share repurchases | 23 | — | — | 18 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | 193 | 321 | 615 | 699 | 643 | 568 | 412 | 364 | 327 | 218 | 183 | 144 | 120 | 104 | 90 | 77 | 62 |
Insider activity
Form 4 filings by officers, directors and 10% owners, November 16, 2024 to November 16, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.
The last 25 transactions
| Traded | Insider | Role | Transaction | Shares | Price | Value | Held after | Filed |
|---|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | Aldag Edward K JR | Chairman, President & CEO, Director | tax withholding | 109,433 | $3.51 | $384K | 7M | Oct 7, 2026 |
| Oct 7, 2026 | Hamner R Steven | Executive Vice President & CFO, Director | tax withholding | 48,548 | $3.51 | $170K | 4M | Oct 7, 2026 |
| Oct 7, 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | tax withholding | 4,048 | $3.51 | $14K | 570,980 | Oct 7, 2026 |
| Oct 7, 2026 | Hanna James Kevin | Senior VP, Controller & CAO | tax withholding | 3,295 | $3.51 | $12K | 539,209 | Oct 7, 2026 |
| Oct 7, 2026 | Williams Rosa Handley | SVP of Operations | tax withholding | 1,938 | $3.51 | $7K | 446,960 | Oct 7, 2026 |
| Oct 7, 2026 | Lambert Charles R | SVP of Finance and Treasurer | tax withholding | 2,347 | $3.51 | $8K | 385,360 | Oct 7, 2026 |
| Aug 20, 2026 | Hanna James Kevin | Senior VP, Controller & CAO | open-market buy | 2,300 | $4.15 | $10K | 542,504 | Aug 20, 2026 |
| Jul 8, 2026 | Lambert Charles R | SVP of Finance and Treasurer | tax withholding | 2,347 | $4.61 | $11K | 387,707 | Jul 8, 2026 |
| Jul 8, 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | tax withholding | 4,048 | $4.61 | $19K | 575,028 | Jul 8, 2026 |
| Jul 8, 2026 | Aldag Edward K JR | Chairman, President & CEO, Director | tax withholding | 109,433 | $4.61 | $504K | 7M | Jul 8, 2026 |
| Jul 8, 2026 | Hamner R Steven | Executive Vice President & CFO, Director | tax withholding | 48,548 | $4.61 | $224K | 4M | Jul 8, 2026 |
| Jul 8, 2026 | Hanna James Kevin | Senior VP, Controller & CAO | tax withholding | 3,295 | $4.61 | $15K | 540,204 | Jul 8, 2026 |
| Jul 8, 2026 | Williams Rosa Handley | SVP of Operations | tax withholding | 1,938 | $4.61 | $9K | 448,898 | Jul 8, 2026 |
| Apr 8, 2026 | Aldag Edward K JR | Chairman, President & CEO, Director | tax withholding | 109,433 | $4.67 | $511K | 7M | Apr 8, 2026 |
| Apr 8, 2026 | Hamner R Steven | Executive Vice President & CFO, Director | tax withholding | 48,548 | $4.67 | $227K | 4M | Apr 8, 2026 |
| Apr 8, 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | tax withholding | 4,048 | $4.67 | $19K | 579,076 | Apr 8, 2026 |
| Apr 8, 2026 | Lambert Charles R | SVP of Finance and Treasurer | tax withholding | 2,347 | $4.67 | $11K | 390,054 | Apr 8, 2026 |
| Apr 8, 2026 | Williams Rosa Handley | SVP of Operations | tax withholding | 1,938 | $4.67 | $9K | 450,836 | Apr 8, 2026 |
| Apr 8, 2026 | Hanna James Kevin | Senior VP, Controller & CAO | tax withholding | 3,295 | $4.67 | $15K | 543,499 | Apr 8, 2026 |
| Mar 18, 2026 | Williams Rosa Handley | SVP of Operations | award | 21,250 | $0.00 | — | 452,774 | Mar 19, 2026 |
| Mar 18, 2026 | Williams Rosa Handley | SVP of Operations | award | 42,500 | $0.00 | — | 431,524 | Mar 19, 2026 |
| Mar 18, 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | award | 37,500 | $0.00 | — | 583,124 | Mar 19, 2026 |
| Mar 18, 2026 | Portal Larry H | SVP, Senior Advisor to the CEO | award | 75,000 | $0.00 | — | 545,624 | Mar 19, 2026 |
| Mar 18, 2026 | Lambert Charles R | SVP of Finance and Treasurer | award | 50,000 | $0.00 | — | 367,401 | Mar 19, 2026 |
| Mar 18, 2026 | Lambert Charles R | SVP of Finance and Treasurer | award | 25,000 | $0.00 | — | 392,401 | Mar 19, 2026 |
Full insider history for Medical Properties Trust, Inc., or insider activity across all companies. A record of filings, not a recommendation.
Tracked funds holding it
1 of the tracked managers held MPT in their latest 13F filing, through November 12, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded MPT by quarter.
| Fund | Manager | Quarter | Value | Shares | Weight | Move |
|---|---|---|---|---|---|---|
| Renaissance Technologies | Peter Brown | Q3 2026 | $292K | 84,400 | 0.00% | new |
Sources
Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.
- Filer
- MEDICAL PROPERTIES TRUST INC, CIK 1287865 on EDGAR
- Extract generated
- November 16, 2026
- Withheld
- 17 line-years whose four quarters do not sum to the filed year: depreciation amortization FY2010, depreciation amortization FY2011, revenue FY2011, depreciation amortization FY2012, depreciation amortization FY2013, depreciation amortization FY2014, depreciation amortization FY2015, depreciation amortization FY2016, depreciation amortization FY2017, depreciation amortization FY2018, depreciation amortization FY2019, depreciation amortization FY2020, depreciation amortization FY2021, depreciation amortization FY2022, income tax FY2022, depreciation amortization FY2023, depreciation amortization FY2025
- Repaired
- 2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: income tax FY2018, other income FY2022
XBRL concepts behind each line
Income statement
RevenuesCostOfGoodsAndServicesSoldGeneralAndAdministrativeExpenseOperatingIncomeLossNonoperatingIncomeExpenseIncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterestIncomeTaxExpenseBenefitNetIncomeLossEarningsPerShareDilutedWeightedAverageNumberOfDilutedSharesOutstandingBalance sheet
CashAndCashEquivalentsAtCarryingValueAssetsLongTermDebtLongTermDebtLiabilitiesStockholdersEquitydei:EntityCommonStockSharesOutstandingCash flow statement
NetCashProvidedByUsedInOperatingActivitiesDepreciationAndAmortization, DepreciationDepletionAndAmortizationPaymentsForRepurchaseOfCommonStockPaymentsOfOrdinaryDividendsThe data
The statements on this page as files, generated November 16, 2026.
- JSON file
/data/financials/MPT.json